Staidson BioPharm
30020421.974.92% ( +1.03 )
Staidson BioPharm (300204)
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research, development, production, and marketing of therapeutic and biological drugs in...
- Open
- 20.69
- High
- 22.28
- Low
- 20.68
- Prev. Close
- 20.94
- Volume
- 275.53K
- Turnover
- 601.63M
- Avg Price
- 21.84
- Bid/Ask Ratio
- --
- Amplitude
- 7.64%
- 52wk High
- 66.66
- Volume Ratio
- 0.44
- Turnover Ratio
- 5.77%
Staidson BioPharm Analyst Rating
View MoreForecast & Rating
Jun 15, 2025Price forecast
¥55.24151.43%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- 36Kr · Mar 31 at 05:25 AM
Institutions bought Pingtan Development and 17 other stocks today, selling Eastroc Beverage for 363 million yuan
- etnet · Nov 5, 2025 at 08:33 PM
"A-Share Focus" Staidson BioPharm plummets 8.5%, the third-largest shareholder plans to reduce holdings
- Zhitong · Oct 31, 2025 at 03:25 AM
Staidson BioPharm today hit a 20% limit up, with 5 institutional special seats net buying 229 million yuan
- Zhitong · Oct 28, 2025 at 05:56 AM
Staidson BioPharm released its performance for the first three quarters, with a net loss attributable to the parent company of 30.6895 million yuan
- Zhitong · Oct 26, 2025 at 03:17 AM
Staidson BioPharm: Application for stock issuance to specific objects accepted by Shenzhen Stock Exchange
- Zhitong · Oct 16, 2025 at 08:44 PM
Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit up
